Prieto Isabel, Hermoso Francisco, Gasparo Marc de, Vargas Félix, Alba Francisco, Segarra Ana B, Banegas Inmaculada, Ramírez Manuel
Unit of Physiology, University of Jaén, Bldg B-3, 23071 Jaén, Spain.
Peptides. 2003 May;24(5):755-60. doi: 10.1016/s0196-9781(03)00121-9.
In spite of the well-known contribution of angiotensin II (Ang II) in the pathogenesis of Goldblatt two-kidney one clip (G2K1C) hypertension, the importance of other Ang peptides, such as Ang III, Ang IV or Ang 2-10, is scarcely understood. The functional status of these peptides depends on the action of several aminopeptidases called angiotensinases. The metabolism of Ang III to Ang IV by aminopeptidase M (AlaAP) and of Ang I to Ang 2-10 by aspartyl aminopeptidase (AspAP) was evaluated in the renal cortex and medulla of normotensive (Sham-operated) and hypertensive (G2K1C) rats, treated or not with the AT(1) receptor antagonist valsartan. The results demonstrated a highly significant increase of membrane-bound (MEMB) AlaAP in the cortex of the non-ischemic kidney of G2K1C rats compared with the kidney of normal rats and with the clipped kidney of G2K1C rats. This suggests an increased formation of Ang IV in the non-clipped kidney of G2R1C rats. Valsartan reduced MEMB AlaAP and AspAP activities in the renal cortex of normotensive and in the clipped kidney of hypertensive rats. The reduced metabolism of Ang III may prolong its half-life in valsartan-treated animals. These results suggest a role for AlaAP in renovascular hypertension. In addition, the higher AspAP activity of the renal cortex compared to medulla reflects its relative functional difference between both locations.
尽管血管紧张素II(Ang II)在Goldblatt二肾一夹(G2K1C)高血压发病机制中的作用已广为人知,但其他血管紧张素肽,如Ang III、Ang IV或Ang 2 - 10的重要性却鲜为人知。这些肽的功能状态取决于几种称为血管紧张素酶的氨肽酶的作用。在接受或未接受AT(1)受体拮抗剂缬沙坦治疗的正常血压(假手术)和高血压(G2K1C)大鼠的肾皮质和髓质中,评估了氨肽酶M(AlaAP)将Ang III代谢为Ang IV以及天冬氨酰氨肽酶(AspAP)将Ang I代谢为Ang 2 - 10的情况。结果表明,与正常大鼠的肾脏以及G2K1C大鼠的夹闭肾脏相比,G2K1C大鼠非缺血肾脏皮质中膜结合(MEMB)AlaAP显著增加。这表明G2R1C大鼠非夹闭肾脏中Ang IV的生成增加。缬沙坦降低了正常血压大鼠肾皮质以及高血压大鼠夹闭肾脏中MEMB AlaAP和AspAP的活性。Ang III代谢的减少可能会延长其在缬沙坦治疗动物体内的半衰期。这些结果表明AlaAP在肾血管性高血压中发挥作用。此外,肾皮质中AspAP活性高于髓质,这反映了两者在功能上的相对差异。